Moderna Inc (MRNA)

Interest coverage

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands -3,583,000 -2,399,000 -4,374,000 -4,837,000 -3,974,000 -2,400,000 714,000 4,897,000 9,420,000 13,250,000 15,640,000 16,261,000 13,297,000 7,619,496 3,833,558 650,875 -734,623 -589,533 -481,389 -500,532
Interest expense (ttm) US$ in thousands 24,000 24,000 28,000 35,000 38,000 42,000 40,000 32,000 29,000 25,000 21,000 21,000 18,000 15,508 14,342 11,220 9,886 8,373 7,082 6,745
Interest coverage -149.29 -99.96 -156.21 -138.20 -104.58 -57.14 17.85 153.03 324.83 530.00 744.76 774.33 738.72 491.33 267.30 58.01 -74.31 -70.41 -67.97 -74.21

December 31, 2024 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $-3,583,000K ÷ $24,000K
= -149.29

The interest coverage ratio of Moderna Inc has exhibited significant fluctuations over the past years. From the negative values reported in the earlier periods up to December 2021, indicating that the company's earnings were insufficient to cover its interest expenses, to the substantial improvements seen in the following quarters up to June 2022, reaching the peak levels recorded in March 2022.

However, the ratio started to decline thereafter, showing a decreasing trend but remained at relatively healthy levels until September 2023. From September 2023 onwards, the interest coverage ratio turned negative again, implying that the company's earnings were not enough to cover its interest payments during these periods. This negative trend continued until the end of December 2024.

Overall, the interest coverage ratio of Moderna Inc has displayed a volatile pattern, indicating various changes in the company's ability to meet its interest obligations with operating income. Investors and creditors should closely monitor this ratio to assess the company's financial health and ability to service its debt in the future.


See also:

Moderna Inc Interest Coverage (Quarterly Data)